Assessment of the role of interleukin 17A and interleukin 17F in chronic hepatitis C virus infection in Egyptian patients

Background/purpose of the study Chronic hepatitis C virus (HCV) infection is considered one of the major health problems. About 170 million patients were infected with HCV worldwide. Till few years, Egypt was considered the highest HCV prevalent country worldwide, with predominant genotype number 4....

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed F Gomaa (Author), Mohammed O Wahba (Author), Raghda Abd El Lateif Hafez (Author), Omar Mohamed Eldaly (Author), Shahenda Gamal Badran (Author)
Format: Book
Published: SpringerOpen, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e3a32bbb97984c78a7e3cf9a5046b31c
042 |a dc 
100 1 0 |a Ahmed F Gomaa  |e author 
700 1 0 |a Mohammed O Wahba  |e author 
700 1 0 |a Raghda Abd El Lateif Hafez  |e author 
700 1 0 |a Omar Mohamed Eldaly  |e author 
700 1 0 |a Shahenda Gamal Badran  |e author 
245 0 0 |a Assessment of the role of interleukin 17A and interleukin 17F in chronic hepatitis C virus infection in Egyptian patients 
260 |b SpringerOpen,   |c 2019-01-01T00:00:00Z. 
500 |a 1110-7782 
500 |a 2090-9098 
500 |a 10.4103/ejim.ejim_119_18 
520 |a Background/purpose of the study Chronic hepatitis C virus (HCV) infection is considered one of the major health problems. About 170 million patients were infected with HCV worldwide. Till few years, Egypt was considered the highest HCV prevalent country worldwide, with predominant genotype number 4. The host immunity plays a major role in HCV infection with evolving data confirming the role of T-helper 17 cells in the formation of chronic HCV infection. The aim of our work was to determine the role of interleukins 17A (IL17A), 17F (IL17F) in the formation of chronic hepatitis C infection. Patients and methods We classify the patients into two groups: the first group included 51 chronic HCV patients who did not take antiviral therapy (the study group) and the second group included 51 healthy blood donors (as a control group). The levels of IL17A and IL17F in the serum of both groups were measured using the sandwich enzyme-linked immunosorbent assay method. Results The serum values of IL17A were higher in patients with chronic HCV than the other group with the mean values being 52.9±32.6 pg/ml in the patient group and 17.1±10.4 pg/ml in the control group. IL17F was slightly higher in the HCV patient group than the control group, but it was statistically insignificant. Moreover, there were significant positive correlations between IL17A and alanine aminotransferase, viral load, and degree of liver fibrosis. Conclusion Patients with chronic HCV infections had a higher serum level of IL17A than the normal persons and it is positively correlated with alanine aminotransferase, viral load, and degree of liver fibrosis. This suggests its pivotal role in the formation of chronic HCV infection; so, it can be used as a new marker for disease progression due to its positive correlation with the severity of liver injury. 
546 |a EN 
690 |a hepatitis C virus 
690 |a immune response 
690 |a interleukin 17 
690 |a T-helper cells 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n The Egyptian Journal of Internal Medicine, Vol 31, Iss 2, Pp 199-202 (2019) 
787 0 |n http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=2;spage=199;epage=202;aulast=Gomaa 
787 0 |n https://doaj.org/toc/1110-7782 
787 0 |n https://doaj.org/toc/2090-9098 
856 4 1 |u https://doaj.org/article/e3a32bbb97984c78a7e3cf9a5046b31c  |z Connect to this object online.